These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 37242892)
21. CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles. Chiesa E; Greco A; Riva F; Dorati R; Conti B; Modena T; Genta I Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056160 [TBL] [Abstract][Full Text] [Related]
22. Nanocarriers based novel and effective drug delivery system. Khizar S; Alrushaid N; Alam Khan F; Zine N; Jaffrezic-Renault N; Errachid A; Elaissari A Int J Pharm; 2023 Feb; 632():122570. PubMed ID: 36587775 [TBL] [Abstract][Full Text] [Related]
23. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review. Hossen S; Hossain MK; Basher MK; Mia MNH; Rahman MT; Uddin MJ J Adv Res; 2019 Jan; 15():1-18. PubMed ID: 30581608 [TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications. Widjaja LK; Bora M; Chan PN; Lipik V; Wong TT; Venkatraman SS J Biomed Mater Res A; 2014 Sep; 102(9):3056-65. PubMed ID: 24124098 [TBL] [Abstract][Full Text] [Related]
25. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles. Cai J; Fu J; Li R; Zhang F; Ling G; Zhang P Carbohydr Polym; 2019 Mar; 208():356-364. PubMed ID: 30658811 [TBL] [Abstract][Full Text] [Related]
26. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel. Wang X; Cheng R; Zhong Z Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162 [TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
28. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment. Rao NV; Yoon HY; Han HS; Ko H; Son S; Lee M; Lee H; Jo DG; Kang YM; Park JH Expert Opin Drug Deliv; 2016; 13(2):239-52. PubMed ID: 26653872 [TBL] [Abstract][Full Text] [Related]
29. Carbon nanotubes for delivery of small molecule drugs. Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402 [TBL] [Abstract][Full Text] [Related]
30. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery. Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy. Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163 [TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390 [TBL] [Abstract][Full Text] [Related]
33. Nano-drug delivery system for the treatment of acute myelogenous leukemia. Zhang S; Sun J Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):233-240. PubMed ID: 35713321 [TBL] [Abstract][Full Text] [Related]
34. Preparation of hyaluronic acid-decorated mixed nanomicelles for targeted delivery of hydrophobic drugs to CD44-overexpressing cancer cells. Soleymani M; Velashjerdi M; Asgari M Int J Pharm; 2021 Jan; 592():120052. PubMed ID: 33159986 [TBL] [Abstract][Full Text] [Related]
35. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo. Wang J; Li Y; Wang L; Wang X; Tu P Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064 [TBL] [Abstract][Full Text] [Related]
36. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions. Raj R; Mongia P; Kumar Sahu S; Ram A Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484 [TBL] [Abstract][Full Text] [Related]
37. Fabrication of hyaluronic acid-based micelles with glutathione-responsiveness for targeted anticancer drug delivery. Yan K; Feng Y; Gao K; Shi X; Zhao X J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1586-1596. PubMed ID: 34500160 [TBL] [Abstract][Full Text] [Related]
38. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview. Kapalatiya H; Madav Y; Tambe VS; Wairkar S Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612 [TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells. Cao X; Tao L; Wen S; Hou W; Shi X Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334 [TBL] [Abstract][Full Text] [Related]
40. Recent Biomedical Approaches for Chitosan Based Materials as Drug Delivery Nanocarriers. Iacob AT; Lupascu FG; Apotrosoaei M; Vasincu IM; Tauser RG; Lupascu D; Giusca SE; Caruntu ID; Profire L Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]